The evaluation of lung doses for radiation pneumonia risk in stereotactic body radiotherapy: A comparison of intensity modulated radiotherapy, intensity modulated arc therapy, cyberknife and helical tomotherapy

被引:2
作者
Okutan, M. [1 ]
Franko, A. [1 ]
Koksal, C. [1 ]
Goksel, E. O. [2 ]
Karaman, S. [3 ]
Akpinar, Y. Emre [4 ]
Dagoglu, N. [2 ]
Demir, B. [5 ]
机构
[1] Oncol Inst, Dept Med Phys, Universty Istanbul, Istanbul, Turkey
[2] Universty Acibadem Mehmet Ali Aydinlar, Dept Radiotherapy, Vocat Sch Hlth Serv, Istanbul, Turkey
[3] Universty Istanbul, Dept Radiat Oncol, Oncol Inst, Istanbul, Turkey
[4] Universty Istanbul, Dept Radiol, Istanbul Med Fac, Istanbul, Turkey
[5] Universty Istanbul, Dept Phys, Istanbul Sci Fac, Istanbul, Turkey
来源
INTERNATIONAL JOURNAL OF RADIATION RESEARCH | 2020年 / 18卷 / 04期
关键词
Radiation pneumonia; stereotactic body radiotherapy; intensity modulated radiotherapy; intensity modulated arc therapy; cyberknife; helical tomotherapy; CANCER; CARCINOMA; TUMORS;
D O I
10.18869/acadpub.ijrr.18.4.633
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Radiation Pneumonia (RP) is one of the most extensive side effects in Stereotactic Body Radiotherapy (SBRT) of lung cancer. SBRT are performed by means of Intensity Modulated Radiotherapy (IMRT), Intensity Modulated Arc Therapy (IMAT), CyberKnife (CK) or Helical Tomotherapy (HT) treatment methods. In this study, we performed a plan study to determine the plan parameter such as the Mean Lung Dose (MLD), V-20Gy Lung Volume and V-5Gy Lung Volume in the evaluation of RP risk in the treatment of lung with SBRT. Materials and Methods: Fifteen patients with Lung Cancer who had a tumor diameter of less than 5 cm and peripheral located were included to this study. Intensity Modulated Radiotherapy, Intensity Modulated Arc Therapy, CyberKnife and Helical Tomotherapy plans were separately created for each patients. For each plan, a total of 54 Gy dose were given to Planning Target Volume (PTV) in 3 fractions using a dose of 18 Gy per fraction. Results: In each technique for all parameters of PTV and critical organ doses (OAR) meet the required criteria. Total Lung MLD were found as 3.21 Gy and Total Lung V-20Gy Volume were found as 4.05 cc, Total Lung V-5Gy Volume were found as 14.06 cc as the lowest value in IMRT-SBRT plan. Conclusion: When treatment plans are evaluated in terms of RP risk, Total Lung MLD, Total Lung V-20Gy Volume and Contralateral Lung V-5Gy Volume are found the lower in IMRT - SBRT plan than other SBRT techniques. We suggest that IMRT-SBRT irradiation should be preferred in lung radiotherapy in case of high RP risk.
引用
收藏
页码:633 / 640
页数:8
相关论文
共 19 条
  • [1] [Anonymous], 2009, SEAMLESS PHASE 1 2 S
  • [2] Atalar B, 2008, TURK ONCOL DERG, V23, P109
  • [3] A DOSE-VOLUME ANALYSIS OF RADIATION PNEUMONITIS IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH STEREOTACTIC BODY RADIATION THERAPY
    Barriger, R. Bryan
    Forquer, Jeffrey A.
    Brabham, Jeffrey G.
    Andolino, David L.
    Shapiro, Ronald H.
    Henderson, Mark A.
    Johnstone, Peter A. S.
    Fakiris, Achilles J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 457 - 462
  • [4] Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy
    Borst, Gerben R.
    Ishikawa, Masayori
    Nijkamp, Jasper
    Hauptmann, Michael
    Shirato, Hiroki
    Onimaru, Rikiya
    van den Heuvel, Michel M.
    Belderbos, Jose
    Lebesque, Joos V.
    Sonke, Jan-Jakob
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) : 307 - 313
  • [5] STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CARCINOMA: FOUR-YEAR RESULTS OF A PROSPECTIVE PHASE II STUDY
    Fakiris, Achilles J.
    McGarry, Ronald C.
    Yiannoutsos, Constantin T.
    Papiez, Lech
    Williams, Mark
    Henderson, Mark A.
    Timmerman, Robert
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : 677 - 682
  • [6] Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy
    Guckenberger, Matthias
    Baier, Kurt
    Polat, Buelent
    Richter, Anne
    Krieger, Thomas
    Wilbert, Juergen
    Mueller, Gerd
    Flentje, Michael
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 97 (01) : 65 - 70
  • [7] Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - Can we distinguish recurrence from fibrosis? A systematic review of the literature
    Huang, Kitty
    Dahele, Max
    Senan, Suresh
    Guckenberger, Matthias
    Rodrigues, George B.
    Ward, Aaron
    Boldt, R. Gabriel
    Palma, David A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 102 (03) : 335 - 342
  • [8] Analysis of Dose Distribution and Risk of Pneumonitis in Stereotactic Body Radiation Therapy for Centrally Located Lung Tumors: A Comparison of Robotic Radiosurgery, Helical Tomotherapy and Volumetric Modulated Arc Therapy
    Kannarunimit, Danita
    Descovich, Martina
    Garcia, Aaron
    Chen, Josephine
    Weinberg, Vivian
    Mcguinness, Christopher
    Pinnaduwage, Dilini
    Murnane, John
    Gottschalk, Alexander R.
    Yom, Sue S.
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2015, 14 (01) : 49 - 60
  • [9] RADIATION-THERAPY ALONE FOR STAGE-I NONSMALL CELL LUNG-CANCER
    KASKOWITZ, L
    GRAHAM, MV
    EMAMI, B
    HALVERSON, KJ
    RUSH, C
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (03): : 517 - 523
  • [10] Intensity-modulated radiation therapy
    Lee, N. Y.
    Terezakis, S. A.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (08) : 691 - 696